(Reuters) - Shares of Valeant Pharmaceuticals International Inc fell on Thursday after the campaign of Democratic presidential contender Hillary Clinton posted a blog from an Iowa event detailing exorbitant price hikes for a migraine drug made by the company.




Source: Clinton targets Valeant price hikes in campaign appearance


David Cottle

UBB Owner & Administrator